GlobeNewswire Inc.··Not SpecifiedTarsus Pharmaceuticals Accelerates XDEMVY Growth, Eyes $670M-$700M 2026 Sales
Tarsus reports Q1 2026 XDEMVY sales exceeding $145M, up 85% YoY, while maintaining full-year guidance of $670M-$700M.
TARSinvestor conferencesQ1 2026 earnings